I-125 seeds brachytherapy combined with immunotherapy for MET amplification in non-small cell lung cancer from clinical application to related lncRNA mechanism explore: a case report

Advanced non-small cell lung cancer (NSCLC) with MET amplification primarily relies on MET inhibitors for treatment, but once resistance occurs, the available treatment options are limited and the prognosis is typically poor. A 57-year-old man with advanced NSCLC and C-MET amplification was initiall...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Mingxing, You, Yuanli, Wang, Xiuqing, Dong, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300560/
https://www.ncbi.nlm.nih.gov/pubmed/37389354
http://dx.doi.org/10.3389/fcell.2023.1176083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300560/
https://www.ncbi.nlm.nih.gov/pubmed/37389354
http://dx.doi.org/10.3389/fcell.2023.1176083

Ejemplares similares